Xeloda Stomach Cancer Filing Will Likely Reach EU Before FDA, Roche Says
This article was originally published in The Pink Sheet Daily
Executive Summary
A pivotal trial found Xeloda in combination with cisplatin was non-inferior to the current standard-of-care for advanced gastric cancer, firm says.